The influence of biomaterials on inflammatory responses to cardiopulmonary bypass

Forbes CD , Courtney JM Thrombosis and artificial surfaces. In: Bloom AL , Forbes CD , Thomas DP , Tuddenham EGD eds. Haemostasis and thrombosis, third edition. Edinburgh: Churchill Livingstone , 1993: 1301-24.

Courtney JM , Lamba Nmk , Sundaram S. , Forbes CD Biomaterials for blood-contacting applications. Biomaterials 1994; 15: 737-44.

Courtney JM , Sundaram S. , Forbes CD Extracorporeal situations: biocompatibility of biomaterials. In: Forbes CD , Cushieri A eds. Management of bleeding disorders in surgical practice. Oxford: Blackwell Scientific , 1993 : 236-76.

Courtney JM , Sundaram S. , Matata BM , Gaylor Jds , Forbes CD Biomaterials in cardiopulmonary bypass. Perfusion 1994; 9: 3-10.

Courtney JM , Sundaram S. , Lamba Nmk , Forbes CD Monitoring of the blood response in blood purification. Artif Organs 1993; 17: 260-66.

Brash JL Role of plasma protein adsorption in the response of blood to foreign surfaces . In: Sharma CP , Szycher M eds. Blood compatible materials and devices. Lancaster, PA: Technomic , 1991: 3-24.

Davie EW , Fujikawa K. , Kisiel W. The coagulation cascade - initiation, maintenance, and regulation . Biochemistry 1991; 30: 10363-70.

Pearson JD Vessel wall interactions regulating thrombosis. Br Med Bull 1994; 50: 776-88.

Gravlee GP , Haddon WS , Rothberger HK et al. Heparin dosing and monitoring for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 518-27.

Tanaka T. , Takao M. , Yada I. , Yuasa H. , Kusagawa M. , Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anaesth 1989; 3: 181-88.

Boisclair MD , Lane DA , Philippou H. , Sheikh S. , Hunt B. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F 1+2. Thromb Haemost 1993; 70: 253-58.

Burman JF , Chung HI , Lane DA , Philippou H. , Adami A. , Lincoln Jcr. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet 1994; 344: 1192-93.

Griffin JH , Cochrane CG Recent advances in the understanding of contact activation reactions . Semin Thromb Hemost 1979; 5: 254-73.

Silverberg M. , Dunn JT , Garen L. , Kaplan AP Auotoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem 1980; 255: 7281-86.

Dunn JT , Silverberg M. , Kaplan AP The cleavage and formation of activated Hageman factor by autodigestion and by kallikrein. J Biol Chem 1982; 275: 1779-84.

Colman RW Surface-mediated defense reactions: the plasma contact activation system. J Clin Invest 1984; 73: 1249-53.

Schmaier AH , Smith PM , Colman RW Contact activation and its abnormalities. In: Colman RW , Marder VJ , Salzman W eds. Haemostasis and thrombosis. Basic principles and clinical practice. JP Lippincott, Philadelphia, 1987: 18-38.

Matata BM , Wark S. , Sundaram S. et al. In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents. Biomaterials 1995; 16: 1305-12.

Scott CF , Silver LD , Schapira M. , Colman RW Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity: evidence that this molecule exists as a procofactor . J Clin Invest 1984; 73: 954-62.

Wachtfogel YT , DeLa Cadena RA, Colman RW. Structural biology, cellular interactions and pathophysiology of the contact system. Thromb Res 1993; 72: 1-21.

Tankersley DL , Finlayson JS Kinetics of activation and autoactivation of human factor XII. Biochemistry 1984; 23: 273-79.

Regoli D. , Rhaleb NE , Draplan G. , Dion S. Kinin receptor subtypes. J Cardiovasc Pharmacol 1990; 15: S30-S38.

Boisclair MD , Land DA , Philippou H. et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82: 3350-57.

Mitropoluos KA , Miller GJ , Watts GF , Nurrington PN Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein lipase deficiency . Atherosclerosis 1992; 94: 119-25.

Ghebrehiwet B. , Randazzo BP , Dunn JT , Silverberg M. , Kaplan AP Mechanism of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest 1983; 71: 1450-56.

Bennett B. , Booth NA , Ogston D. Potential interactions between complement, coagulation, fibrinolysis, kinin-forming and other enzyme systems, In: Bloom AL , Thomas DP eds. Haemostasis and thrombosis , Edinburgh: Churchill Livingstone , 1987: 473-95.

Fuhrer G. , Gallimore MJ , Heller W. , Hoffmeister HE FXII. Blut 1990; 61: 258-66.

Kluft C. , Jie Afh. Interaction between the extrinsic and intrinsic systems of fibrinolysis . In: Davison JF , Cepelak V , Samama MY , Desnoyers PC eds. Progress in chemical fibrinolysis and thrombolysis. Edinburgh: Churchill Livingstone, 1979: 25-31.

Colman RW Activation of plasminogen by human kallikrein. Biochem Biophys Res Commun 1969; 35: 273-79.

Goldsmith G. , Saito H. , Ratnoff OD The activation of plasminogen by Hageman factor (FXII) and Hageman factor fragments. J Clin Invest 1978; 62: 54-60.

Mandle R. Jr, Kaplan AP Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis . J Biol Chem 1977; 252: 6097-104.

Gallimore MJ , Fareid E. , Stormorken H. The purification of a plasma kallikrein with a weak plasminogen activator activity. Thromb Res 1978; 12: 409-20.

Kaplan AP , Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15.

Egberg N. , Gallimore MJ , Green K. , Jacobsson J. , Vesterqvist O. , Wiman B. Effects of plasma kallikrein and bradykinin infusions into pigs on plasma fibrinolytic variables and urinary excretion of thromboxane and prostacyclin metabolites. Fibrinolysis 1988; 2: 101-106.

Huisveld IA , Haspers H. , Van Heeswijk GM , Bernink Mje , Erich Wbm , Bouma BN Contribution of contact activation factors to urokinase-related fibrinolytic activity in whole human plasma. Thromb Haemostas 1985; 54: 102.

Lu H. , Soria C. , Commin P-L. et al. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol). Thromb Haemostas 1991; 66: 633-37.

Tanaka K. , Miromoto T. , Yada I. , Kusacawa M. , Deguchi K. Physiologic role of enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery. Trans Am Soc Artif Intern Organs 1987; 33: 505-509.

Stibbe J. , Kluft C. , Brommer EJ , Gomes M. , de Jong DS , Naura I. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator . Eur J Clin Invest 1984; 14: 375-82.

Gram J. , Janetzko T. , Jespersen J. , Bruhn HD Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemostas 1990; 63: 241-45.

Scott CF , Silver LD , Purdon AD , Colman RW Cleavage of human high molecular weight kininogen by factor XIa in vitro: effect on structure and function. J Biol Chem 1985; 260: 10856-63.

Chenoweth DE Complement activation produced by biomaterials . Trans Am Soc Artif Intern Organs 1986; 32: 226-32.

Matsuda T. Biological responses at non-physiological interfaces and molecular design of biocompatible surfaces. Nephrol Dial Transplant 1989; 4(suppl): 60-66.

Johnson RJ Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994; 9(suppl 2): 36-45.

Anderson DC , Schmalstieg FC , Arnaut MA et al. Abnormalities of polymorphonuclear leukocyte function associated with an heritable deficiency of high molecular weight surface glycoproteins (GP 138): common relationship to diminished cell adherence. J Clin Invest 1984; 74: 536-51.

Springer TA , Thompson WS , Miller LJ , Schmalstieg FC , Anderson DC Inherited deficiency of the MAC-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984; 160: 1901-18.

Zimmermann GA , McIntyre TM Neutrophil adherence to human endothelium in vivo occurs by CDw18 (Mol, MAC-1/LFA-1/GP150,95) glycoprotein-dependent and -independent mechanisms. J Clin Invest 1988; 81: 531-37.

Cotran RS , Gimbrone MA Jr, Bevilacqua MP , Mendrick DL , Pober JS Induction and detection of human endothelial activation antigen in vivo. J Exp Med 1986; 164: 661-66.

Bevilacqua MP , Pober JS , Wheeler ME , Cotran RS , Gimbrone MA Jr. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 1985; 76: 2003-11.

Marlin SD , Springer TA Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987; 51: 813-19.

Dustin ML , Rothlein R. , Bhan AK , Dinarello CA , Springer TA Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adhesion molecule (ICAM-1). J Immunol 1986; 137: 245-54.

Stauton DE , Marlin SD , Stratowa C. , Dustin ML , Springer TA Primary structure of ICAM-1 demonstrates interaction between members of immunoglobulin and integrin supergene families. Cell 1988 ; 52: 925-33.

Bevilacqua MP , Pober JS , Mendrick DL , Cotran RS , Gimbrone MA Jr.Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238-42.

Edmunds LH Jr.Blood-surface interactions during cardiopulmonary bypass. J Cardiac Surg 1993; 8: 404-10.

Downing SW , Edmunds LH Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 1236-43.

Royston D. Blood cell activation. Semin Thorac Cardiovasc Surg 1990; 2: 341-57.

Pober JS , Gimbrone MA , Lapierre LA et al. Activation of human endothelium by lymphokines: overlapping patterns of antigenic modulation by interleukin-1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137: 1893-96.

Moser R. , Schleiffenbaum B. , Groscurt P. , Fehr J. Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 1989; 83: 444-55.

Pohlman TH , Stanness KA , Beatty PG , Ochs HD , Harlan JM An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin-1, and tumor necrosis factor increases neutrophil adherence by CDw18-dependent mechanisms. J Immunol 1986 ; 136: 4548-53.

Casey LC Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56: S92-S96.

Windsor AC , Mullen PG , Flower AA , Sugarman HJ Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 1993; 80: 10-17.

Chenoweth DE , Cooper SW , Hugli TE , Stewart RW , Blackstone EH , Kirklin JW Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins . N Engl J Med 1981; 304: 497-503.

Okusawa S. , Yancey KB , van der Meer Jwm et al. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin-1b and interleukin-1a. J Exp Med 1988; 168: 443-48.

Beutler B. , Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379-85.

Klebanoff S. , Vadas MA , Harlan JM et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136: 4220-25.

Tracey KJ , Vlassara H. , Cerami A. Cachectin/tumour necrosis factor. Lancet 1989 ; i: 1122-26.

Lotz M. Interleukin-6. Cancer Invest 1993; 11: 732-42.

Butler J. , Chong GL , Baigrie RJ , Pillai R. , Westaby S. , Rocker GM Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation . Ann Thorac Surg 1992; 53: 833-38.

Finn A. , Naik S. , Klein N. , Levinsky RJ , Strobel S. , Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-41.

Kawamura T. , Wakusawa R. , Okada K. , Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin-8 and 6 in reperfusion injury. Can J Anaesth 1993; 40: 1016-21.

Kalfin RE , Engelman RM , Rounsou JA et al. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 1993; 88: 401-406.

Strieter RM , Kunkel SL , Showell HJ et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-a, LPS and IL-1b Science 1989 ; 243: 1467-69.

Haeffner-Cavaillon N. , Roussellier N. , Ponzio O. et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98: 1100-106.

Butler J. , Baigrie RJ , Parker D. et al. Systemic inflammatory response to cardiopulmonary bypass: a pilot study of the effects of pentoxyfilline. Resp Med 1993; 87: 285-88.

Granowitz EV , Santos AA , Poutsiaka DD et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991; 338: 1423-24.

Hannum CH , Wilcox CJ , Arend WP et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336-40.

Eisenberg FP , Evans RJ , Arend WP et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341-66.

Weerwind PW , Maessen JG , van Tits Ljh et al. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg 1995; 110: 1633-41.

Lantz M. , Malik S. , Slevin ML et al. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 1990; 2: 402-406.

Van Zee KJ , Kohno T. , Fisher E. et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-alfa in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845—49.

Spinas GA , Keller U. , Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992; 90: 553-56.

Cassatella MA , Meda L. , Gasperini S. , Calzetti F. , Bonora S. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist from lipopolysaccharide stimulated polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994 ; 179: 1695-99.

Leeuwenberg JF , Jeunhomme TM , Buurman WA Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994; 152: 4036-43.

McBride WT , Armstrong MA , Crockard AD et al. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995; 75: 724-33.

Courtney JM , Irvine L. , Jones C. , Mosa SM , Robertson LM , Srivastava S. Biomaterials in medicine - a bioengineering perspective. Int J Artif Organs 1993; 16: 165-71.

Courtney JM , Lamba Nmk , Gaylor Jds , Ryan CJ , Lowe Gdo. Blood-contacting biomaterials: bioengineering viewpoints. Artif Organs 1995; 19: 852-56.

Yu J. , Sundaram S. , Weng D. , Courtney JM , Moran CR , Graham NB Blood interactions with novel polyurethaneurea hydrogels. Biomaterials 1991; 12; 119-20.

Yin HQ , Lamba Nmk , Gaylor Jds , Courtney JM , Blass CR , Lowe Gdo. In vitro blood compatibility assessment of tubular materials. Int J Artif Organs 1994; 17: 433.

Boonstra PW , Gu YJ , Akkermann C. , Haan J. , Huyzen R. , van Oeveren W. Heparin coating of an extracorporeal circuit partly improves haemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 107: 289-92.

Weerwind PW , Reutelingsperger Cpm , Lindhout T. et al. Clinical evaluation of Duraflo II heparin-treated extracorporeal circuits on the activation of the kinin and coagulation system. Proc Am Acad Cardiovasc Perfusion 1994; 15: 62-69.

Gu YJ , van Oeveren W. , Akkerman C. , Boonstra PW , Huyzen RJ , Wildevuur Crh. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 917-22.

Steinberg BM , Grossi AE , Schwartz SD et al. Heparin bonding of bypass reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 525-29.

Yu J. , Lamba Nmk , Courtney JM et al. Influence of phosphorylcholine groups on protein adsorption and complement activation. Int J Artif Organs 1994; 17: 499-504.

von Segesser LK , Schilling J. , Leskosek B. , Marquardt K. , Turina M. Surface treatments for perfusion devices. Perfusion 1994; 9: 197-205.